紫杉醇

Paclitaxel is a chemotherapy medication used to treat various types of cancer, including ovarian, breast, and lung cancer.
紫杉醇是一种化疗药物，用于治疗包括卵巢癌、乳腺癌和肺癌在内的多种癌症。
The patient was administered paclitaxel as part of her treatment regimen for metastatic breast cancer.
患者在接受转移性乳腺癌治疗方案中被给予紫杉醇。
Paclitaxel works by interfering with the normal division of cancer cells, thereby inhibiting tumor growth.
紫杉醇通过干扰癌细胞的正常分裂，从而抑制肿瘤生长。
Researchers found that combining paclitaxel with carboplatin significantly improved response rates in patients with advanced non-small cell lung cancer.
研究人员发现将紫杉醇与卡铂联合使用能显著提高晚期非小细胞肺癌患者的响应率。
Adverse effects associated with paclitaxel therapy include hair loss, fatigue, and peripheral neuropathy.
与紫杉醇疗法相关的不良反应包括脱发、疲劳和周围神经病变。
In the clinical trial, paclitaxel showed efficacy in prolonging survival in patients with recurrent epithelial ovarian cancer.
在临床试验中，紫杉醇显示出在延长复发性上皮性卵巢癌患者生存期方面的疗效。
Paclitaxel is typically administered intravenously over several hours, under close medical supervision.
紫杉醇通常在严密的医疗监护下，以静脉滴注的方式，在数小时内完成给药。
The development of paclitaxel resistance remains a significant challenge in the treatment of advanced-stage cancers.
对紫杉醇产生耐药性仍然是治疗晚期癌症面临的重要挑战。
Patients undergoing paclitaxel treatment often require premedication with corticosteroids to reduce the risk of hypersensitivity reactions.
接受紫杉醇治疗的患者通常需要预先使用皮质类固醇来降低过敏反应的风险。
A novel formulation of paclitaxel, bound to albumin, was developed to improve its solubility and potentially decrease side effects.
为了提高紫杉醇的溶解度并可能减少副作用，研究人员开发了一种与白蛋白结合的新配方紫杉醇。